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Presence of extended spectrum beta-lactamases (ESBL) in bacteria is a growing health con-
cern  of global signiﬁcance. The local, regional, national, and international epidemiological
studies for extended spectrum beta-lactamases-producing Enterobacteriaceae and their
encoding genes in foods are still incomplete. The objective of this study was to determine the
occurrence of extended spectrum beta-lactamases-producing Enterobacteriaceae and the
characteristics of their encoding genes from a total of 250 samples of various foods of animal-
origin (100 raw chicken meat, 100 raw cow milk, and 50 raw cow milk cheese) sold in Turkey.
Overall, 55 isolates were positive as extended spectrum beta-lactamases-producing Entero-
bacteriaceae. The most prevalent extended spectrum beta-lactamases-producing strain
were identiﬁed as Escherichia coli (80%), followed by Enterobacter cloacae (9.1%), Citrobacter
braakii (5.5%), Klebsiella pneumoniae (3.6%), and Citrobacter werkmanii (1.8%) by Vitek® MS. The
simultaneous production of extended spectrum beta-lactamases and AmpC was detected in
ﬁve  isolates (9.1%) in E. coli (80%) and E. cloacae (20%). The frequency rates of blaTEM, blaCTX-M,
and  blaSHV were 96.4%, 53.7%, and 34.5%, respectively. The co-existence of bla-genes was
observed in 82% of extended spectrum beta-lactamases producers with a distribution of
blaTEM & blaCTX-M (52.7%), blaTEM & blaSHV (20%), blaTEM & blaCTX-M & blaSHV (12.7%), and blaSHV
& blaCTX-M (1.8%). The most prevalent variant of blaCTX-M clusters was deﬁned as blaCTX-M-1
(97.2%), followed by blaCTX-M-8 (2.8%). In summary, the analysed foods were found to be pos-
ing  a health risk for Turkish consumers due to contamination by Enterobacteriaceae with a
diversity of extended spectrum beta-lactamases encoding genes. Bras ra de Microbiologia. Published by Elsevier Editora Ltda. This is©  2016 Sociedade∗ Corresponding author.
E-mail: ihakkitekiner@aydin.edu.tr (I˙.H. Tekiner).
http://dx.doi.org/10.1016/j.bjm.2015.11.034
1517-8382/© 2016 Sociedade Brasileira de Microbiologia. Published by 
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)ileian open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ntroduction
ntibiotics are used as veterinary and human medicines for
reatment, control and prevention of infectious diseases. How-
ver, their repeated off-label over use can have un-anticipated
dverse effects including development of antibiotic resistance
n the bacteria towards modern beta-lactam antibiotics.1
One of the antibiotic resistance mechanisms in the bacteria
s the production of speciﬁc enzymes such as beta-lactamase
o break down the four-atom beta-lactam ring of the antibi-
tics. When this ring is opened through hydrolysis by these
nzymes, the antimicrobial properties of the antibiotics are
ompletely lost.2 The extended spectrum beta-lactamases
ESBL) are the rapidly evolving plasmid-mediated group of
eta-lactamases.3 ESBL can hydrolyse penicillins, ﬁrst, sec-
nd and third-generation cephalosporins, and aztreonam (but
ot cephamycins or carbapenems). The activity of ESBL can be
nhibited by beta-lactamase inhibitors such as clavulanic acid
CLA).4 The antibiotic resistance leads to increased morbid-
ty, mortality and the cost of treating infections, in particular,
hose caused by ESBL-producing bacteria.5 The most prevalent
xtended spectrum beta-lactamases are TEM, SHV, and CTX-M
ariants.6 The CTX-M variants are also clustered in ﬁve major
roups: 1, 2, 8, 9, and 25.7 After 2000s, CTX-M type enzymes
ave exhibited a rapid growth over a wide range geographic
reas, and have become much more  prevalent than TEM and
HV type enzymes.8
The ESBLs are mainly encoded by plasmids and mobile
enetic elements such as integrons, insertion sequences,
ransposons and plasmids. These genetic elements are eas-
ly transferable to other bacteria such as those belonging to
nterobacteriaceae.5,9 The widespread use of third genera-
ion cephalosporins and aztreonam has led to the emergence
nd dissemination of ESBL producing strains and their encod-
ng genes, in particular, among Enterobacteriaceae associated
ith severe enteric illnesses.10–13
The major genes responsible for ESBL production include
EM genes (blaTEM), SHV genes (blaSHV), and CTX-M genes
blaCTX-M).14 This continued evolution is a serious threat to
he public health by limiting the ability to treat bacterial
nfections.15,16 Most of the medicines under human consump-
ion are antibiotics. Moreover, antibiotic use in veterinary
edicine and for growth promotion and disease prevention
n agriculture, aquaculture and horticulture is also a huge
roblem of antibiotic resistance, since most of the antibiotics
anufactured (100,000–200,000 tonnes per year) is estimated
o be massively consumed by these sectors, especially in
he food-producing animals for last 60 years.17,18 There-
ore, food-producing animals and foods of animal-origin are
nder suspicion for being transmission vectors for coloni-
ation and infection of the humans with ESBL-producing
nterobacteriaceae.11,16
The potential contribution of foods to human health
isks by dissemination of plasmid-born ESBLs should be
pidemiologically assessed because local, regional, national
nd international information related to this emerging phe-
omenon is largely incomplete in various geographical
ocations, including Turkey.9,19 The Turkish authorities accept
hat the use of antibiotics in the food animals to make themo l o g y 4 7 (2 0 1 6) 444–451 445
grow faster and/or to prevent disease cannot be controlled
effectively due to the economic beneﬁts of food-animals,
as the sector largely ignores risks associated with human
and animal health.20 Therefore, chicken meat, raw milk and
cheese can be identiﬁed as high risk-carrying contributors
for ESBL-producing Enterobacteriaceae and their encoding
genes.9
The objective of this study was to determine the occurrence
of ESBL-producing Enterobacteriaceae and the frequency rates
of corresponding encoding genes in various foods of animal
origin sold in Turkey.
Materials  and  methods
Reference  cultures
An ESBL-negative strain Escherichia coli ATCC®25922 and an
ESBL-positive strain Klebsiella pneumoniae ATCC®700603 were
used as negative and positive controls, respectively, in the
phenotypic and genotypic methods.
Sampling,  sample  preparation,  isolation  and  identiﬁcation
of ESBL  suspicious  bacteria
During the period of May 2014 to November 2014, a total of 250
food samples of animal origin (100 packed raw chicken meat
from public bazaars, markets and poultry farms, 100 raw cow
milk from containers and holding tanks in bazaars and dairy
farms, and 50 unpacked raw cow milk cheese from bazaars and
markets) were randomly collected in different cities of Mar-
mara, Aegean and Black Sea regions. All samples were placed
into sampling bags, and taken to the laboratory in a thermobox
container at 4 ◦C. The sample preparation and further exami-
nations were quickly started after the sampling.
Ten millilitres of raw milk in 90 mL  of Enterobacteriaceae
Enrichment Broth (LABM, Lancashire, England), and 25 g either
of raw cow milk, cheese or raw chicken meat in 225 mL of
the mentioned broth was homogenised in a sterile bag (Inter-
science, Saint Nom, France) for 2 min  by a stomacher (EasyMix,
AES Chemunex, Rennes, France), and followed by an aerobic
incubation at 37 ◦C for 18–24 h.21 After that, 10 L of the pre-
enriched suspension was directly streaked onto ChromaticTM
ESBL selective media (Lioﬁlchem, Istanbul, Turkey). The inoc-
ulated plates were incubated at 37 ◦C for 18–24 h under aerobic
condition as per to the manufacturer’s instructions. The pre-
sumptive ESBL colonies were then sub-cultured onto Tryptic
Soy Agar (LABM, Lancashire, England), followed by an incuba-
tion at 37 ◦C for 18–48 h. The species identiﬁcation of suspected
ESBL isolates was performed by Vitek® MS (bioMérieux, Marcy
l’Etoile, France).
Screening  and  conﬁrmation  of  ESBLs
Presumptive ESBL-producers were screened using cefpo-
doxime (CPD; 10 g), cefotaxime (CTX; 30 g), and ceftazidime
(CAZ; 30 g) antibiotic discs (MAST Group, UK). A 0.5 McFar-
land standard inoculum of the isolate was spread onto Mueller
Hinton Agar (LABM, Lancashire, England) plates. The discs
were inserted on the plate, and allowed for incubation at 37 ◦C
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Table 1 – Primer design, sequences, amplicon sizes and thermocycler conditions for bla-genes according to 23, 24.
Primer (F/R) Sequence Amplicon size (bp) Thermocycler condition (TC)
blaTEM-F 5′-GCTCACCCAGAAACGCTGGT-3′ 686 TC-1
blaTEM-R 5′-CCATCTGGCC CCAGTGCTGC-3′
blaSHV-F 5′-CCCGCAGCCGCTTGAGCAAA-3′ 733 TC-2
blaSHV-R 5′-CATGCTCGCCGGCGTATCCC-3′
blaCTX-M-F 5′-SCSATGTGCAGYACCAGTAA-3′ 585 TC-3
blaCTX-M-R 5′-ACCAGAAYVAGCGGBGC-3′
blaCTX-M-1-F 5′-AAA AAT CAC TGC GCC AGT TC 415 TC-4
blaCTX-M-1-R 5′-AGC TTA TTC ATC GCC ACG TT
blaCTX-M-2-F 5′-CGA CGC TAC CCC TGC TAT T 552
blaCTX-M-2-R 5′-CCA GCG TCA GAT TTT TCA GG
blaCTX-M-8-F 5′-TCG CGT TAA GCG GAT GAT GC 666
blaCTX-M-8-R 5′-AAC CCA CGA TGT GGG TAG C
blaCTX-M-9-F 5′-CAA AGA GAG TGC AAC GGA TG 205
blaCTX-M-9-R 5′-ATT GGA AAG CGT TCA TCA CC
blaCTX-M-25-F 5′-GCA CGA TGA CAT TCG GG 327
blaCTX-M-25-R 5′-AAC CCA CGA TGT GGG TAG C
TC-1: 1 cycle for 15 min at 95 ◦C, followed by 35 cycles for 1 min at 95 ◦C, 1 min at 63 ◦C, and 1 min at 72 ◦C, and ﬁnally 10 min at 72 ◦C.
TC-2: 1 cycle for 15 min at 95 ◦C, followed by 30 cycles for 30 s at 94 ◦C, 30 s at 58.5 ◦C, and 45 s at 72 ◦C, and ﬁnally 10 min at 72 ◦C.
TC-3: 1 cycle for 15 min at 95 ◦C, followed by 30 cycles for 30 s at 94 ◦C, 30 s at 55 ◦C, and 45 s at 72 ◦C, and a ﬁnal elongation at 72 ◦C for 10 min.
, andTC-4: 1 cycle for 15 min at 94 ◦C; 5 cycles for 25 s at 94 ◦C, 40 s at 52 ◦C
50 s at 72 ◦C, and a ﬁnal elongation at 72 ◦C for 6 min.
for 18–24 h. The breakpoints with zone diameters were eval-
uated according to the criteria established by.22 The ESBL Set
D67C (MAST Group, UK) with a combination of CPD, CTX, and
CAZ ± clavulanate (CLA, 10 g) was used for disc diffusion con-
ﬁrmation test. The disc inserted plates were incubated at 37 ◦C
for 18–24 h. The zone of inhibition was evaluated according to
the criteria described by 22.
Determination  of  minimal  inhibitory  concentration  (MIC)
Micronaut-S beta-lactamase VII Plate (Merlin Diagnostika,
Berlin, Germany) was used for the phenotypic detection of
ESBL-production, including AmpC, metallo-beta-lactamase
(MBL), and carbapenemase (KPC) according to the criteria
described by 22. A 50 L aliquot of 0.5 McFarland-standardised
microbial suspension of the isolate was initially vortexed in
10 mL  of Mueller Hinton Broth (Merck, Darmstadt, Germany).
Subsequently, 100 L of this suspension was pipetted into each
well of the plate. After that, the plate was incubated overnight
at 37 ◦C. The reading was recorded using a Thermoﬁsher Mul-
tiskan FC Spectrometer. The MIC  analysis was automatically
performed by the MCN6 Software (Siﬁn, Berlin, Germany).
Extraction  of  bacterial  DNA
Total DNA of ESBL-producing isolates was extracted using the
GENESpin DNA Isolation Kit (Euroﬁns, Hamburg, Germany)
according to the manufacturer’s instructions. The extracted
DNA samples were stored at –20 ◦C for further molecular anal-
yses.
Characterisation  of  the  bla  variantsThe primer pairs as previously described by 23 were used for
screening of blaTEM, blaSHV and blaCTX-M. The blaCTX-M variants
(blaCTX-M-1, blaCTX-M-2, blaCTX-M-8, blaCTX-M-9, and blaCTX-M-25) 50 s at 72 ◦C, followed by 22 cycles for 25 s at 94 ◦C, 40 s at 54 ◦C, and
were sub-characterised according to 24. All primers were pre-
pared by Fullgen Biotechnology and I˙ontek (I˙stanbul, Turkey).
The ampliﬁcation was performed by a Thermal Cycler PTC-
0200G DNA Engine (BioRad, Istanbul, Turkey). The blaTEM,
blaSHV and blaCTX-M were ampliﬁed in a singleplex PCR assay
while a multiplex PCR assay was performed for blaCTX-M
variants. The PCR mixtures were prepared in a ﬁnal vol-
ume  of 25 L. All PCR conditions were optimised again as
shown in Table 1. Gel-electrophoresis of the PCR products was
performed on a 1.5% agarose-gel. The amplicons were photo-
graphed by GelDoc 2000 imaging system (BioRad, Istanbul,
Turkey). Finally, the analysis was carried-out using Quantity
One 4.6.3 GelDoc XR Software (BioRad, Istanbul, Turkey).
Statistical  analysis
The Kruskal–Wallis H-test was used for multiple comparison
of the proportions of ESBL producers in their sampling groups.
The test statistic H was approximated by a 2 distribution. All
statistical analyses were performed using SPSS 19 (SPSS Inc.,
USA) statistical package programme, and a P-value < 0.05 was
considered as statistically signiﬁcant.
Results
In this study, we screened, for ESBL-producing Enterobacte-
riaceae, 100 raw chicken meat samples, 100 raw cow milk
samples, and 50 raw cow milk cheese samples from differ-
ent cities of Marmara, Agean and Black Sea regions, and
subsequently characterised their encoding blaTEM, blaSHV and
blaCTX-M variants.Phenotypic  results
The phenotypic testing indicated that a total of 55 isolates (29
in raw chicken meat, 24 in raw cow milk, and 2 in raw cow milk
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Table 2 – Screening results of the samples for ESBL-producing Enterobacteriaceae.
Origin No of sample (n, %) No of ESBL + isolates (n, %) Species-based distribution (n, %)
E. coli E. cloacae K. pneumoniae C. brakii C. werkmanii
Raw chicken meat 100 (40%) 29 (52.7%) 24 (82.8%) 2 (6.9%) 2 (6.9%) – 1 (3.4%)
Raw cow milk 100 (40%) 24 (43.6%) 18 (75%) 3 (12.5%) – 3 (12.5%) –
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Total 250 (100%) 55 (100%) 
heese) from 250 food samples of animal origin were positive
or ESBL-producing Enterobacteriaceae. The most prevalent
henotype was E. coli (80%), followed by Enterobacter cloacae
9.1%), Citrobacter braakii (5.5%), K. pneumoniae (3.6%), and Cit-
obacter werkmanii (1.8%) (Table 2).
The disc approximation tests were performed by using
PD, CAZ, and CTX ± CLA containing discs according
o the criteria set by 22. The average zone differences
f CAZ ± CLA, CTX ± CLA and CPD ± CLA were found
s 6.83 ± 3.66 mm,  11.97 ± 6.08 mm and 12.76 ± 6.06 mm
n chicken meat, respectively, and 7.92 ± 5.07 mm,
3.33 ± 4.78 mm and 12.63 ± 7.11 mm in cow milk, respectively,
hile 10.00 ± 0.00 mm,  15.00 ± 4.24 mm and 14.50 ± 2.12 mm
n cow milk cheese, respectively (Table 3).
The MIC  determination revealed that 62.1% of the isolates
rom raw chicken meat were resistant to CTX, 55.2% to CAZ,
1.7% to CEP, 20.6% to COX, and 6.9% to CMC, while among
he isolates from raw cow milk, 79.2% were resistant to CAZ,
5% to CTX, 66.6% to CEP, 54.2% to COX, 4.2% to ERT, and 4.2%
o CMC. Two isolates from raw-cow-milk cheese were 100%
esistant to CTX, CAZ, CEP, and CMC.
Among the 55 ESBL producers, ﬁve isolates (9.1%) were also
ositive for AmpC. Based on the species, the AmpC-producing
solates were E. coli (80%) and E. cloacae (20%) from raw chicken
eat (n = 1), raw cow milk (n = 3), and raw-cow-milk cheese
n = 1). They were resistant to CAZ (100%), CTX and CEP (80%),
MC (40%), and COX (20%).
enotypic  results
n the genotypic analysis, the PCR products were identiﬁed: 53
s blaTEM, 36 as blaCTX-M, and 19 as blaSHV. In the 36 blaCTX-M,
5 were clustered as blaCTX-M-1, and one as blaCTX-M-8. The
laTEM was found in multiple combinations with blaCTX-M-1 &
laCTX-M-8 in 29, with blaSHV in 11, and with blaSHV & blaCTX-M-1
Table 3 – Zone diameters of CPD, CTX, and CAZ ± CLA.
Antibiotic agent Raw chicken meat (n = 29) Raw
Mean (mm) Std. deviation (±mm) Mean (mm)
CAZ 18.24 5.125 16.25 
CAZ CLA 25.07 6 24.17 
1 6.83 3.665 7.92 
CTX 15.59 6.196 11.29 
CTX CLA 27.55 6.3 24.63 
2 11.97 6.08 13.33 
CPD 7.03 5.723 2.13 
CPD CLA 19.79 5.87 14.75 
3 12.76 6.063 12.63 2 (100%) – – – –
44 (80%) 5 (9.1%) 2 (3.6%) 3 (5.5%) 1 (1.8%)
in 7. The blaSHV was detected in a combination with blaCTX-M-1
only in one instance. Of the 44 E. coli isolates, representing the
most prevalent ESBL-producing phenotype, a co-existing dis-
tribution of bla genes was observed as blaTEM & blaCTX-M-1 in 25,
blaSHV & blaTEM in six, blaSHV & blaTEM & blaCTX-M-1 in 6, blaSHV
& blaCTX-M-1 in one, blaTEM & blaCTX-M-8 in one, blaTEM alone in
four, and blaCTX-M-1 alone in one, respectively (Table 4).
Statistical  results
The multiple comparison of the proportions of ESBL producers
in their sampling groups was performed using Kruskal–Wallis
H-test (H = 5.935; P < 0.05). The test statistic H was approxi-
mated by 2 distribution (CI 95%; 2 = 12.5291; P = 0.001). Since
H was less than 2, no statistically signiﬁcant difference was
observed for the association between ESBL proportions and
their sampling groups (P < 0.05) with respect to the food types
of animal origin.
Discussion
In this study, we screened for ESBL-producing Enterobacteria-
ceae from raw chicken meat, raw cow milk and raw-cow-milk
cheese samples. Subsequently, we  characterised genotypi-
cally their encoding genes. The results highlighted that 55
isolates were positive for ESBL-producing Enterobacteriaceae;
ESBL-producing E. coli (80%) was the most frequent species; a
combination of blaTEM & blaCTX-M (52.7%) was the most com-
mon  pattern; and the major variant of blaCTX-M was deﬁned as
blaCTX-M-1 (97.2%), respectively.The ESBL encoding genetic elements are transferable
between the same and different bacterial species.4,25 A study
reported that the antibiotic residues in calf urine resulted
in ampliﬁcation of the populations of antibiotic resistant
 cow milk (n = 24) Raw-cow-milk cheese (n = 2)
 Std. deviation (±mm) Mean (mm) Std. deviation (±mm)
4.057 14.5 3.536
4.603 24.5 3.536
5.073 10 0
4.428 12 1.414
4.817 27 5.657
4.779 15 4.243
4.047 6 0
7.837 20.5 2.121
7.113 14.5 2.121
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Table 4 – genotypic characteristics of 55 ESBL-producers
isolated.
Source Species No of
isolates
ESBL-type
detected by PCR
Raw chicken
meat
E.  coli 3 blaTEM
E. coli 12 blaTEM &
blaCTX-M-1
E. coli 1 blaTEM &
blaCTX-M-8
E. coli 6  blaTEM & blaSHV
E. coli 2  blaTEM & blaSHV &
blaCTX-M-1
E. cloacae 1 blaTEM
E. cloacae 1 blaTEM & blaSHV
C. werkmanii 1 blaTEM
K. pneumoniae 2  blaTEM & blaSHV &
blaCTX-M-1
Raw cow milk E.  coli 1 blaTEM
E. coli 13 blaTEM &
blaCTX-M-1
E. coli 1 blaSHV &
blaCTX-M-1
E. coli 3 blaTEM & blaSHV &
blaCTX-M-1
E. cloacae 3  blaTEM
C. brakii 3  blaTEM & blaSHV
Raw-cow-milk E.  coli 1 blaTEM & blaSHV &
cheese blaCTX-M-1
E. coli 1 blaCTX-M-1
bacteria in the pen soil; and presumably, this increased the
probability of transmission of these resistant populations to
calves and then the animal-derived food chain.26 This might
lead to a risk for infection and colonisation of the human
intestinal microbiome with ESBL producing bacteria such as E.
coli, E. cloacae,  Klebsiella spp., Salmonella spp., Proteus spp. and
Citrobacter spp., through various foods of animal origin27–30;
when these foods are directly consumed without undergoing
any thermal process, or used for raw milk cheese production.31
Due to this threat, the Codex Alimentarius Commission estab-
lished an intergovernmental task force.32 Following that, in
2014, the Standard Committee of European Doctors (CPME),
the Council of European Dentists (CED) and the Federation
of Veterinarians of Europe (FVE) issued a common press
release for all the authorities to manage the problem of ESBL-
producing Enterobacteriaceae (www.fve.org). In our study, a
high occurrence of ESBL producers and their encoding genes
in the examined foods of animal origin indicate a health risk
for the Turkish consumers.
Since the early 2000s, E. coli has become the most con-
cerned member for infection and colonisation of the food
animals.33–36 An ESBL-producing E. coli associated mortality
was three-times higher than non-ESBL producing E. coli.37 The
National Surveillance Network by the Ministry of Health in
Turkey (www.uhes.saglik.gov.tr) has reported an increasing
prevalence of ESBL-producing E. coli (33.2% in 2008 and 48.83%
in 2013) and ESBL-producing K. pneumoniae (40% in 2008 and
49.69% in 2013). However, the role of foods in the dissemina-
tion of ESBL-producing bacteria and their encoding genes to
humans has not been addressed so far in Turkey. In our study,
the frequency of ESBL-producing E. coli was similar to those b i o l o g y 4 7 (2 0 1 6) 444–451
reported in Portugal (85%)38 and Spain (93.3%),33 while it was
higher than those reported in Denmark (1.3%),39 India (3.1%),40
China (12.4%),41 Germany (53.9%),42 Belgium (45%),43 Austria
(24%)44 and Taiwan (10.5%).36 Our study also points E. coli being
an important foodborne ESBL carrier.
Numerous phenotypic methods have been developed to
detect ESBL production by Enterobacteriaceae. However, it is
not still clear which tests are the most sensitive.45 In our
study, the phenotypic screening and conﬁrmation of ESBL pro-
duction were performed by the disc approximation tests. All
of the used disc combinations showed good sensitivities in
accordance with the criteria established by 22. After the disc
approximation tests, MIC  was determined due to the pres-
ence of ESBL encoding genes on the same plasmid.46 The
MIC revealed that 55 ESBL producers were resistant to CTX
(MIC ≥ 4 g/mL) and CAZ (MIC ≥ 16 g/mL), and partly vari-
able to CPD (MIC ≥ 8 g/mL). Basically, TEM and SHV type
beta-lactamases are resistant to CAZ, and variable to CTX
while CTX-M type beta-lactamase exhibits resistance to CPD
and variable to CAZ because CTX-M type beta-lactamase
may escape from screening by CAZ. A survey in Europe
reported that up to 33% of ESBLs strains remained undetected,
therefore, in this case, genotypic conﬁrmation is further
needed.47–50 In our study, the phenotypic results indicated that
TEM and CTX-M type beta lactamases were the most com-
monly encountered ESBLs.
The co-existence of ESBL and AmpC beta-lactamases is
a worldwide growing concern.5,51 ESBL and AmpC produc-
ing enterobacteria have been clinically reported as 19.5% in
Europe, and as 13.9% in Turkey.52,53 In our study, AmpC pro-
ducers were E. coli and E. cloacae,  as reported earlier.52,54,55
Failure to detect these beta lactamases has contributed to
their uncontrolled spread and sometimes the consequent
therapeutic failures.56 For Enterobacteriaceae, the use of
either cefepime (CEP) or cefpirome (CPO) ± CLA is recom-
mended since they are un-affected by AmpC.51 In contrast,
our results revealed that AmpC producers were 100% resis-
tant to CEP + CLA. This indicates that the techniques to
detect AmpC beta-lactamase are still evolving and are not yet
optimised.57
The genotypic characterisation by PCR assays revealed
that blaTEM was the most frequent gene, followed by blaCTX-M
and blaSHV. In Turkey, the clinically reported most frequent
beta-lactamase type was CTX-M, followed by TEM and SHV,
while another study reported a frequency of SHV higher than
TEM.15,58,59 Our genotypic results reporting the most frequent
genes as blaTEM & blaCTX-M were also epidemiologically simi-
lar to the most commonly encountered ESBL encoding genes
in chicken meat from Eastern Europe and Near East,7 South-
ern America,30,60 Tunisia,61 Northern European countries,33
Japan,62,63 Germany,64 China,35 Austria65 and India,40 followed
by the raw milk from Spain,21 England66 and Taiwan36, and
by the cheese and dairy products from Portugal,38 England,66
Iran67 and Egypt,68 respectively. However, the foodborne
ESBL-producing bacteria and their encoding genes in Turkey
have not been addressed till date, and the foodborne beta-
lactamases have been studied only by disc approximation
testing, excluding genotypic characterisation.69–71 Therefore,
our study conﬁrms that the foods of animal origin in Turkey
are potential reservoirs of diverse ESBL encoding genes with
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 co-resistance pattern, which can be disseminated to clinical
nd community settings.
We  detected CTX-M-1 cluster as the most prevalent sub-
ype of CTX-M type beta lactamases. Chromosomal bla gene,
luC, present in Kluyvera cryocrescens is the ancestor of CTX-M-
 cluster.72 The CTX-M type ESBLs are currently recognised
s the part of the most threatening mechanism of antibi-
tic resistance in clinical and community settings, virtually
nvading all human and animal compartments as well as the
nvironment all over the world, and are increasingly being pre-
ominant form in Enterobacteriaceae worldwide.47,72–74 South
merica is known as an important source of CTX-M type ESBL
riginated from clinical settings.75 In Turkey, CTX-M-1 group
as found in 86.8% of the clinical E. coli isolates.76 Our results
howed that the dissemination of CTX-M-1 cluster was not
estricted to the clinical settings, but also involved the foods
f animal origin, causing rapid, important and unpredictable
hanges in the epidemiology of antibiotic resistance.75
In 2007, European Food Safety Authority (EFSA) recom-
ended that bacterial strains containing transferable resis-
ance genes should not be used in animal feeds and fermented
nd probiotic foods for human use.77,78 However, the issue
f antibiotics resistance bacteria in foods has not yet been
eriously raised as a health safety indicator. In conclusion,
he foods of animal origin sold in Turkey have been found as
otential reservoirs for diverse ESBL-producing Enterobacteri-
ceae and their encoding genes with a co-resistance pattern,
hus posing a critical health risk for the Turkish consumers.
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